SCHEMBL30177058

SCHEMBL30177058

Fc1ccc(Nc2cc3cn[nH]c3cc2Br)cc1F

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 3/20 0.49
▸ MKNK1 Q9BUB5 3/20 0.44
▸ CDC7 O00311 2/20 0.42
▸ P2RX7 Q99572 1/20 0.41
▸ EIF2AK2 P19525 1/20 0.40
▸ NOS1 P29475 2/20 0.40
▸ METAP2 P50579 2/20 0.40
▸ CSNK2A1 P68400 1/20 0.40
▸ DYRK1A Q13627 1/20 0.40
▸ KDR P35968 1/20 0.39
▸ TNIK Q9UKE5 1/20 0.39
▸ TRPA1 O75762 2/20 0.39
▸ ROCK2 O75116 1/20 0.38
▸ ROCK1 Q13464 1/20 0.38
▸ SYK P43405 1/20 0.38
▸ AXL P30530 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22655752 1.00 MAOB (0.49) MAOBMKNK1CDC7P2RX7EIF2AK2
SCHEMBL22768248 0.88 P2RX7 (0.41) MAOBMKNK1CDC7P2RX7EIF2AK2
SCHEMBL21856670 0.86 CDC7 (0.53) MKNK1CDC7NOS1METAP2CSNK2A1
SCHEMBL30176980 0.86 CDC7 (0.53) MKNK1CDC7NOS1METAP2CSNK2A1
SCHEMBL22768570 0.85 AXL (0.51) MAOBMKNK1KDRAXL
SCHEMBL21856798 0.81 CDC7 (0.53) MKNK1CDC7NOS1METAP2CSNK2A1
SCHEMBL26321249 0.81 NOS1 (0.41) MKNK1CDC7EIF2AK2NOS1METAP2
SCHEMBL21856857 0.80 MAPT (0.52) NOS1DYRK1A
SCHEMBL30936725 0.77 MAOB (0.40) MAOBMKNK1CDC7TRPA1
SCHEMBL27216867 0.77 MAOB (0.40) MAOBMKNK1CDC7TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114096542-B Condensed tricyclic pyrroles as alpha-1 antitrypsin modulators 弗特克斯药品有限公司 2024-09-10 — — CN disclosed
EP-4126877-A1 PYRROLO[2,3-F]INDAZOLE AND 2,4,5,10-TETRAZATRICYCLO[7.3.0.03,7]DODECA-1,3(7),5,8,11-PENTAENE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD) Vertex Pharmaceuticals Incorporated (US) 2023-02-08 — — EP disclosed
Send feedback